Literature DB >> 11691510

Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery.

P J Gheeraert1, J P Henriques, M L De Buyzere, M De Pauw, Y Taeymans, F Zijlstra.   

Abstract

OBJECTIVES: The goal of this study was to evaluate the effect of preconditioning on out-of-hospital ventricular fibrillation (VF) in patients with acute myocardial infarction (AMI).
BACKGROUND: More than half of the deaths associated with AMI occur out of the hospital and within 1 h of symptom onset. In humans, preinfarction angina (PA), which can serve as a surrogate marker for preconditioning, reduces infarct size, but the protective effect against out-of-hospital VF has not been investigated.
METHODS: Preinfarction angina status and acute coronary angiographic findings of 72 consecutive patients with AMI complicated by out-of-hospital VF were compared with 144 matched controls without this complication.
RESULTS: Preinfarction angina is associated with a lower risk for VF (odds ratio [OR]: 0.40, 95% confidence interval [CI]: 0.18 to 0.88). In patients with acute occlusion of the left coronary artery (LCA) (n = 136), the risk reduction is pronounced (OR: 0.25, 95% CI: 0.10 to 0.66), whereas, in patients with acute occlusion of the right coronary artery (RCA) (n = 67), the protective effect of PA on VF was not observed (OR: 2.25, 95% CI: 0.45 to 11.22). Subgroup and multivariate analyses show that the protective effect is independent of cardiovascular risk factors, preinfarction treatment with beta-adrenergic blocking agents or aspirin, the presence of collaterals or residual antegrade flow or the extent of coronary artery disease.
CONCLUSIONS: Preinfarction angina protects against out-of-hospital VF in patients with acute occlusion of the LCA. This protection is independent of risk factors or coronary anatomy. A larger study is needed to examine the apparently different effect in patients with acute occlusion of the RCA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691510     DOI: 10.1016/s0735-1097(01)01561-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  We must identify patients at risk for pre-hospital sudden cardiac arrest at the early phase of myocardial infarction.

Authors:  Santiago Montero; Alain Combes; Matthieu Schmidt
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  Antiarrhythmic and anti-ischaemic effects of angina in patients with and without coronary collaterals.

Authors:  R J Edwards; S R Redwood; P D Lambiase; E Tomset; R D Rakhit; M S Marber
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

3.  Predictors of early ventricular fibrillation before reperfusion therapy for acute ST-elevation myocardial infarction.

Authors:  J P S Henriques; P J Gheeraert; F Zijlstra; A W J van 't Hof; M-J de Boer; J-H E Dambrink; A T M Gosselink; J C A Hoorntje; J P Ottervanger; H Suryapranata
Journal:  Neth Heart J       Date:  2004-01       Impact factor: 2.380

4.  Preconditioning reduces QTc value in patients with first non-ST-segment elevation myocardial infarction (NSTEMI).

Authors:  Christodoulos E Papadopoulos; Haralampos I Karvounis; Georgios E Parharidis; Georgios E Louridas
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

5.  Patients with tombstoning pattern on the admission electrocardiography who have undergone primary percutaneous coronary intervention for anterior wall ST-elevation myocardial infarction: in-hospital and midterm clinical outcomes.

Authors:  Erkan Ayhan; Turgay Isık; Huseyin Uyarel; Mehmet Ergelen; Gokhan Cicek; Servet Altay; Mehmet Eren; Charles Michael Gibson
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

Review 6.  Preconditioning in humans.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

7.  Pre-infarction angina and outcomes in non-ST-segment elevation myocardial infarction: data from the RICO survey.

Authors:  Luc Lorgis; Aurélie Gudjoncik; Carole Richard; Laurent Mock; Philippe Buffet; Philippe Brunel; Luc Janin-Manificat; Jean-Claude Beer; Damien Brunet; Claude Touzery; Luc Rochette; Yves Cottin; Marianne Zeller
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

8.  Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark.

Authors:  Reza Jabbari; Thomas Engstrøm; Charlotte Glinge; Bjarke Risgaard; Javad Jabbari; Bo Gregers Winkel; Christian Juhl Terkelsen; Hans-Henrik Tilsted; Lisette Okkels Jensen; Mikkel Hougaard; Stephanie E Chiuve; Frants Pedersen; Jesper Hastrup Svendsen; Stig Haunsø; Christine M Albert; Jacob Tfelt-Hansen
Journal:  J Am Heart Assoc       Date:  2015-01-05       Impact factor: 5.501

Review 9.  Ischemic preconditioning: protection against myocardial necrosis and apoptosis.

Authors:  Efstathios K Iliodromitis; Antigone Lazou; Dimitrios Th Kremastinos
Journal:  Vasc Health Risk Manag       Date:  2007

10.  Importance of coronary artery disease in sudden cardiac death.

Authors:  Li Shien Low; Karl B Kern
Journal:  J Am Heart Assoc       Date:  2014-10-06       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.